NovMetaPharma Co., Ltd.
Develops first-in-class drugs for metabolic and fibrotic diseases.
229500 | KO
Overview
Corporate Details
- ISIN(s):
- KR7229500004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 언주로 727 13층 (논현동, 트리스빌딩), 강남구
- Website:
- http://www.novmeta.com/
- Sector:
- Manufacturing
Description
NovMetaPharma Co., Ltd. is a biopharmaceutical company specializing in the research and development of first-in-class drugs with differentiated mechanisms. The company focuses on creating novel therapeutics for metabolic and fibrotic diseases, addressing significant unmet medical needs. Its main pipeline includes drug candidates for type 2 diabetes (NovDB2), obesity (NovOB), chronic kidney disease (NovRD), and fibrosis (NovFS). The company's lead assets in clinical development are Cyclo-Z and CHP. NovMetaPharma aims to develop innovative treatments by leveraging its core research teams and efficient development systems to target the root causes of these complex conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-27 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.9 KB | ||
| 2023-03-17 00:00 |
사업보고서 (2022.12)
|
Korean | 1.3 MB | ||
| 2023-03-16 00:00 |
감사보고서제출
|
Korean | 9.2 KB | ||
| 2023-03-16 00:00 |
특허권취득(자율공시)(시클로-히스프로의 신규 폴리모픽형 물질 특허)
|
Korean | 5.3 KB | ||
| 2023-03-15 00:00 |
임상시험단계진입ㆍ종료(자율공시)(당뇨병성 신증 환자를 대상으로 한 신약(NovDKD)의 임상 2상 시험계획(IND) 승인)
|
Korean | 7.3 KB | ||
| 2023-03-10 00:00 |
주주총회소집결의
|
Korean | 13.0 KB | ||
| 2023-03-10 00:00 |
주주총회소집공고
|
Korean | 196.4 KB | ||
| 2023-03-07 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 42.5 KB | ||
| 2023-02-23 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자)
|
Korean | 5.2 KB | ||
| 2023-02-23 00:00 |
소액공모실적보고서
|
Korean | 43.3 KB | ||
| 2023-02-15 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 32.8 KB | ||
| 2023-02-15 00:00 |
소액공모공시서류(지분증권)
|
Korean | 1.5 MB | ||
| 2023-02-13 00:00 |
기타주요경영사항(자율공시)(기술평가 결과)
|
Korean | 5.9 KB | ||
| 2023-02-09 00:00 |
특허권취득(자율공시)
|
Korean | 5.3 KB | ||
| 2023-01-31 00:00 |
특허권취득(자율공시)
|
Korean | 6.1 KB |
Automate Your Workflow. Get a real-time feed of all NovMetaPharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NovMetaPharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NovMetaPharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
